Predictive utility of RRM1 promoter polymorphisms on outcome of patients with non-small cell lung cancer.

被引：0
|
作者：
Haura, EB [1 ]
Zheng, Z [1 ]
Gautam, A [1 ]
Sharma, S [1 ]
Cantor, A [1 ]
Sharma, A [1 ]
Bepler, G [1 ]
Lee, H [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7155
引用
收藏
页码：654S / 654S
页数：1
相关论文
共 50 条
  • [1] Validation of RRM1 and PTEN as prognostic parameters of outcome in non-small cell lung cancer.
    Bepler, G
    Sharma, S
    Cantor, A
    Gautam, A
    Haura, E
    Simon, G
    Sharma, A
    Sommers, E
    Robinson, L
    Lee, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 654S - 654S
  • [2] Predictive role of RRM1 and BRCA1 mRNA expression on the clinical outcome of advanced non-small cell lung cancer
    Liang, J. G.
    Jin, Z. Y.
    Gao, X. D.
    Te, M. R.
    Ge, L. H.
    Wang, C. L.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) : 5292 - 5298
  • [3] The prognostic value of gene expressions of ERCC1 and RRM1 in non-small cell lung cancer.
    Hasturk, Serap
    Olgunus, Ozlem
    Tuli, Abdullah
    Dundar, Ebru
    Unlu, Emine Ozgur
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] RRM1 expression and the clinicopathological characteristics of patients with non-small cell lung cancer treated with gemcitabine
    Chen, Ying
    Huang, Ying
    Chen, Dong-Ming
    Wu, Chao
    Leng, Qiu-Ping
    Wang, Wen-Yi
    Deng, Ming-Qin
    Zhao, Yan-Xia
    Yang, Xiao-Hong
    ONCOTARGETS AND THERAPY, 2018, 11 : 5579 - 5589
  • [5] RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients–a short report
    Chuan Zeng
    Weidong Fan
    Xianquan Zhang
    Cellular Oncology, 2015, 38 : 319 - 325
  • [6] The tailored chemotherapy based on RRM1 immunohistochemical expression in patients with advanced non-small cell lung cancer
    Nie, Xin
    Cheng, Gang
    Ai, Bin
    Zhang, Shuai
    CANCER BIOMARKERS, 2013, 13 (06) : 433 - 440
  • [7] Expression levels of ERCC1 and RRM1 mRNA and clinical outcome of advanced non-small cell lung cancer
    Bi Jian-wei
    Mao Yi-min
    Sun Yu-xia
    Liu Shi-qing
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (05) : 1158 - 1161
  • [8] ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine
    Ulker, Mehmet
    Duman, Berna Bozkurt
    Sahin, Berksoy
    Gumurdulu, Derya
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (03): : 207 - 213
  • [9] RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients-a short report
    Zeng, Chuan
    Fan, Weidong
    Zhang, Xianquan
    CELLULAR ONCOLOGY, 2015, 38 (04) : 319 - 325
  • [10] Response to First-Line Chemotherapy in Patients with Non-Small Cell Lung Cancer According to RRM1 Expression
    Dong, Xiaopeng
    Hao, Yingtao
    Wei, Yucheng
    Yin, Qiuwei
    Du, Jiajun
    Zhao, Xiaogang
    PLOS ONE, 2014, 9 (03):
12345